Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - 35th Annual Meeting of the European Group for Blood and Marrow Transplantation
Secondary Prevention of Invasive Fungal Infections in Stem-cell Transplant Patients
Göteborg, Sweden / March 29-April 1, 2009
Göteborg - The risk of recurrence of a previous invasive fungal infection (IFI) or acquisition of a new one is a major obstacle to the success of stem-cell transplantation (SCT). These infections are increasing in frequency and the majority...
PRIORITY PRESS - 50th Annual Meeting and Exhibition of the American Society of Hematology
New Options in VTE Prophylaxis in the Surgical Setting
San Francisco, California / December 6-9, 2008
San Francisco - Major orthopedic surgery, such as total hip or knee replacement, confers a recognized risk of venous thromboembolism (VTE), including deep-vein thrombosis and pulmonary embolism. To prevent VTE, clinicians traditionally have...
PRIORITY PRESS - Critical Care Canada Forum
Echinocandins in the ICU: A Clinical Advance
Toronto, Ontario / November 11-13, 2008
Invasive and septic Candida infections are associated with high levels of mortality and morbidity. However, the agents most commonly used to empirically treat these pathogens are associated with significant drawbacks: there are now high...
33rd Congress of the European Society for Medical Oncology
Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients
Stockholm, Sweden / September 12-16, 2008
Stockholm - The risk posed by cancer for venous thromboembolism (VTE) and pulmonary embolism appears to be insufficiently appreciated. In patients hospitalized for cancer, anticoagulation is a recognized standard of care, but the much...
13th Congress of the European Hematology Association
Prevention and Treatment of Venous Thromboembolic Disorders: Future Needs
Copenhagen, Denmark / June 12-15, 2008
Copenhagen - Total hip and knee replacement orthopedic surgery patients are in the highest risk category for venous thromboembolic (VTE) sequelae, both deep-vein thrombosis (DVT) and pulmonary embolism, and the risk is known to extend well...
XXVIII International Congress of the World Federation of Hemophilia
Evolution of Recombinant Factor VIII: Progress in Patient Safety
Istanbul, Turkey / June 1-5, 2008
Istanbul - A variety of recombinant FVIII (rFVIII) products are now available to treat patients with hemophilia A. Product safety has improved since the initial use of human and mammalian proteins in first-generation processes. Even less...
XXVIII International Congress of the World Federation of Hemophilia
Improving Quality of Life in Patients with Hemophilia with Inhibitors
Istanbul, Turkey / June 1-5, 2008
Istanbul - The development of antibodies occurs frequently in patients with severe hemophilia A or B, complicating both on-demand and prophylactic treatment. Recommended treatment options include activated prothrombin complex concentrate...
49th Annual Meeting and Exposition of the American Society of Hematology
Less Toxic Broad-Spectrum Antifungals: Facilitating Infection Control in Hematological Malignancies
Atlanta, Georgia / December 8-11, 2007
Atlanta - The substantial morbidity and mortality imposed by invasive fungal infections in patients with hematological malignancies can be largely contained by a high index of suspicion and early use of broad-spectrum antifungal drugs....
49th Annual Meeting and Exposition of the American Society of Hematology
From First-line to Consolidation Therapies: Exploring Options in Hematologic Malignancies
Atlanta, Georgia / December 8-11, 2007
Editorial Overview Joseph M. Connors, MD, ABIM, FRCPC Chair, Lymphoma Tumor Group BC Cancer Agency Clinical Professor of Medicine University of British Columbia Vancouver, British Columbia